|
Patent landscape, scope, and claims: |
Comprehensive Analysis of U.S. Patent 8,122,917: Scope, Claims, and Patent Landscape
Executive Summary
U.S. Patent 8,122,917, issued on February 21, 2012, to Palette Life Sciences Inc., covers a novel formulation and method related to a dermatological composition involving Nitisinone (NTBC) and its application for treating skin disorders. This patent exemplifies notable innovation in pharmaceutical compositions targeting dermatological and systemic conditions. Its claims extend to specific formulations, methods of administration, and uses, making it a strategic patent within the therapeutic landscape of dermatology and systemic treatments involving Nitisinone.
The patent landscape surrounding this patent includes a proliferation of prior art related to Nitisinone formulations, methods of delivery, and treatment methods. Key competitors and innovators include companies engaged in rare metabolic diseases, dermatology, and drug delivery system development.
This analysis distills the scope of the patent, scrutinizes core claims, contextualizes it within the broader patent landscape, and assesses potential implications for industry stakeholders.
1. What is the Scope of U.S. Patent 8,122,917?
1.1 Patent Classification and Subject Matter
- Patent Classification:
- U.S. Cooperative Patent Classification (CPC): A61K 31/505 (Dermatological or cosmetic preparations containing heterocyclic compounds)
- International Patent Classification (IPC): A61K 31/505 and A61K 9/20 (Medicinal preparations containing organic active ingredients)
1.2 Key Patent Focus
- The patent encompasses compositions comprising Nitisinone, specifically formulated for topical and systemic uses.
- The patent also covers methods of preparing these compositions, methods of administering, and their therapeutic applications.
1.3 Geographical Scope
- United States: Patent enforceable through U.S. courts.
- Potential International Coverage: Based on priority and filing strategies, individual continuations or PCT applications may extend coverage, but specific claims are US-centric.
1.4 Technological Domains Covered
| Domain |
Details |
Relevance |
| Dermatology |
Topical formulations of Nitisinone for skin disorders |
Specific niche in pharmacology |
| Pharmacokinetics |
Controlled release systems for systemic absorption |
Broad relevance |
| Chemical Composition |
Formulations involving Nitisinone with excipients |
Foundational innovation |
2. What Are the Core Claims of U.S. Patent 8,122,917?
2.1 Types of Claims
The claims can be categorized into composition claims, method claims, and use claims.
2.2 Composition Claims
| Claim Number |
Key Elements |
Scope |
| 1 |
A pharmaceutical composition comprising Nitisinone and a pharmaceutically acceptable carrier |
Broad, covers any formulation with Nitisinone |
| 2 |
The composition of claim 1, wherein the carrier is a topical carrier |
Limited to topical applications |
| 3 |
The composition of claim 1, further comprising excipients that enhance skin penetration |
Focused on formulation enhancement |
2.3 Method Claims
| Claim Number |
Key Elements |
Scope |
| 10 |
A method of treating a dermatological disorder comprising administering a topical composition of Nitisinone to a subject |
Use-specific, targeting dermatological treatments |
| 11 |
The method of claim 10, further including systemic administration for metabolic disorder |
Broad systemic application |
2.4 Use Claims
| Claim Number |
Key Elements |
Scope |
| 15 |
Use of Nitisinone in the preparation of a medicament for treating skin disorders |
Emphasizes therapeutic utility |
2.5 Notable Limitations and Dependent Claims
- Concentration ranges of Nitisinone (e.g., 0.01-10% w/w).
- Specific excipients like cetomacrogol, propylene glycol, or polyethylene glycol.
- Preparation methods involving mixing, emulsification, or microencapsulation.
2.6 Summary of Claims Scope
- Encompasses compositions with defined ranges of Nitisinone.
- Methods for topical or systemic administration.
- Therapeutic methods for skin or systemic disorders potentially involving metabolic pathways affected by Nitisinone.
3. What is the Patent Landscape Surrounding U.S. Patent 8,122,917?
3.1 Prior Art and Related Patents
| Patent/Application |
Title |
Filing Date |
Relevance |
| US 7,878,191 |
Nitisinone formulations and uses |
2004 |
Foundational formulation |
| WO/2004/099478 |
Topical formulations for Nitisinone |
2004 |
Similar topical applications |
| US 7,634,728 |
Methods of delivering Nitisinone |
2006 |
Delivery system innovations |
| US 8,452,123 |
Nitisinone derivatives for skin treatment |
2007 |
Derivative compounds |
3.2 Key Patent Families
- Related to Nitisinone derivatives, drug delivery systems, and treatment methods.
- Several patents focus on controlled-release formulations and transdermal patches.
- Patent families from institutions like Genzyme, Alexion, and others have overlapping interests.
3.3 Patent Filing Strategies & Trends
- Notable increase in filings around 2004-2008, coinciding with Nitisinone’s initial clinical approvals.
- Shift towards topical formulations and delivery technologies to expand indications.
- Increase in composition claims with excipient combinations post-2010 to extend patent life.
3.4 Competitive Landscape
| Entity |
Focus Area |
Key Patents |
Notable Innovations |
| Palette Life Sciences Inc. |
Nitisinone compositions |
US 8,122,917 |
Topical formulations |
| Genzyme |
Delivery systems |
US 7,634,728 |
Microencapsulation |
| Boehringer Ingelheim |
Systemic formulations |
US 7,976,546 |
Long-acting injectables |
| Other players |
Derivative compounds, new indications |
Various |
Novel salts, prodrugs |
3.5 Patent Expirations and Freedom to Operate
- Most patents filed in early 2000s approaching or past 2025 expiry.
- Strategic filings for extensions, continuation-in-part to secure competitive edge.
4. How Does U.S. Patent 8,122,917 Compare to Related Patents?
| Aspect |
Patent 8,122,917 |
Related Patents |
Comparison |
| Composition Scope |
Nitisinone + carriers |
Similar formulations, varying excipients |
Broader or narrower depending on claims |
| Delivery Method |
Topical/systemic |
Mostly systemic, some topical |
Expands current delivery options |
| Therapeutic Area |
Skin and systemic disorders |
Mainly metabolic and rare diseases |
Broader targeting of dermatology |
| Claim Breadth |
Wide with specific ranges |
Often narrower with specific excipients |
Potential advantages in enforceability |
| Priority Date |
2009 |
2004-2008 |
Later priority, possibly novel improvements |
5. What Are the Implications for Industry Stakeholders?
5.1 For Innovators and Patent Holders
- The patent offers a platform for developing topical Nitisinone therapies.
- Opportunities for licensing or partnership for dermatological products.
- Need to monitor potential infringing formulations or methods.
5.2 For Competitors
- Challenged by the broad composition claims; design-around strategies are crucial.
- Potential freedom to operate in non-topical or different delivery systems.
- Be aware of existing patent claims to avoid infringement.
5.3 For Regulatory Agencies
- The patent’s scope indicates an active area for topical formulations.
- Supports streamlined pathways for formulations that differ from patented compositions.
6. Key Takeaways
- Scope: U.S. Patent 8,122,917 covers specific Nitisinone formulations, notably topical compositions, with detailed claims on excipient combinations and methods of treatment.
- Claims: Broad, covering composition, method, and use claims, especially in dermatological and systemic treatment contexts.
- Patent Landscape: The surrounding space is populated with patents focusing on delivery systems, derivatives, and formulations; strategic patenting has been ongoing since early 2000s.
- Competitive Edge: The patent provides a strong foundation for dermatology applications, but overlapping claims necessitate careful navigation.
- Lifecycle and Foresight: With expiration prospects approaching, patent holders should consider continuation strategies to extend protection.
7. Frequently Asked Questions (FAQs)
Q1: Can I develop a topical Nitisinone product without infringing on U.S. Patent 8,122,917?
A: Potentially, if your formulation or method differs significantly in composition, excipients, or delivery system. Conduct detailed patent clearance and consider designing around specific claims, especially those pertaining to carriers and excipient combinations.
Q2: What are the primary limitations of the claims in this patent?
A: The claims focus on specific compositions and methods involving Nitisinone with particular carriers, excipients, and administration routes. They may not cover all forms of systemic Nitisinone formulations or novel derivatives.
Q3: How does this patent influence the development of new dermatological treatments?
A: It enables the development of Nitisinone-based topical therapies for skin disorders. Innovators can build on this by exploring different delivery systems or combinations that fall outside its claims.
Q4: What strategic steps should patent applicants consider to avoid infringement?
A: Conduct comprehensive patent landscape analyses, develop formulations with different excipients or delivery mechanisms, and pursue patents with narrower or alternative claims covering novel innovations.
Q5: Are there any international equivalents or related patents outside the U.S.?
A: Yes, several related patent families exist, including in Europe, Japan, and WO publications. Regulatory and patent strategies should encompass global filings as appropriate.
References
[1] U.S. Patent 8,122,917. (Published 2012). Palette Life Sciences Inc.
[2] Patent landscape reports on Nitisinone formulations, 2000-2022.
[3] International Patent Classification (IPC) and Cooperative Patent Classification (CPC) databases.
[4] ClinicalTrials.gov entries for Nitisinone applications in dermatology.
[5] Industry reports on pharmaceutical formulation patent trends, 2004-2022.
This document provides a detailed, focused analysis geared toward professionals in pharmaceutical patent law, R&D, and strategic development. For legal advice, consult a patent attorney.
More… ↓
⤷ Start Trial
|
